Digestives & Intestinal Remedies - G20

  • G20
  • In 2024, the revenue generated in the Digestives & Intestinal Remedies market market amounted to US$15.19bn.
  • This market is expected to experience an annual growth rate of 2.40% (CAGR 2024-2029).
  • When compared globally, the highest revenue is generated in China, which amounts to US$4,408.00m in 2024.
  • In terms of per capita revenue, each person generates US$3.06 in 2024.
  • These figures highlight the significant market potential in the Digestives & Intestinal Remedies market market within the G20 countries.
  • In the G20 country of Germany, there is a growing trend towards natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in G20 is witnessing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in the Digestives & Intestinal Remedies market are increasingly seeking natural and organic products that promote digestive health. They are also looking for products that provide quick relief from common digestive issues such as bloating, indigestion, and heartburn. Additionally, customers are becoming more health-conscious and are willing to invest in preventive measures to maintain their digestive health.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and improve digestion. As more people become aware of the benefits of probiotics, the demand for products containing probiotics is increasing.Another trend in the market is the rising demand for digestive enzymes. Digestive enzymes are substances that help break down food into smaller molecules for better absorption. They are particularly beneficial for individuals with digestive disorders or those who have difficulty digesting certain types of food. The increasing prevalence of digestive disorders such as irritable bowel syndrome (IBS) and lactose intolerance is driving the demand for digestive enzyme supplements.

Local special circumstances:
In the United States, the Digestives & Intestinal Remedies market is driven by a large aging population and the high prevalence of digestive disorders. The demand for digestive health products is also influenced by the increasing adoption of unhealthy diets and sedentary lifestyles. Additionally, the popularity of natural and organic products is growing, leading to increased demand for digestive health supplements made from natural ingredients.In China, the Digestives & Intestinal Remedies market is driven by the rising middle class population and increasing disposable income. The Chinese population is becoming more health-conscious and is willing to spend on products that promote digestive health. Traditional Chinese medicine, which emphasizes the importance of maintaining a healthy digestive system, is also contributing to the demand for Digestives & Intestinal Remedies.

Underlying macroeconomic factors:
The growth of the Digestives & Intestinal Remedies market in G20 countries is influenced by several macroeconomic factors. These include population growth, urbanization, and increasing healthcare expenditure. As the population in G20 countries continues to grow and urbanize, the demand for Digestives & Intestinal Remedies is expected to increase. Additionally, the rising healthcare expenditure in these countries is leading to greater awareness and accessibility of digestive health products.In conclusion, the Digestives & Intestinal Remedies market in G20 is experiencing growth due to changing customer preferences, emerging trends such as the popularity of probiotics and digestive enzymes, local special circumstances, and underlying macroeconomic factors. The increasing demand for natural and organic products, the rising prevalence of digestive disorders, and the growing middle class population are driving the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)